Acamprosate CA 333MG tab national cmop

The Department of Veterans Affairs Veterans Health Administration, Veterans Integrated Service Network 15, is seeking to procure Acamprosate CA 333MG enteric-coated tablets in 180-count bottles (NDC 68462-0435-18) through its National CMOP Contracting Office. Qualified vendors must be registered and current in SAM.gov, possess an unexpired state wholesale distributor license demonstrating Drug Supply Chain Security Act compliance, and provide a Trade Agreement Act certificate identifying their place of manufacturing. Responses must include four mandatory documents: a signed SF1449 Solicitation cover page, a pricing schedule in Excel format with place of manufacture information, the required distributor license, and the Trade Agreement Act certificate. The RFQ number is 36C77026Q0092, with a response deadline of March 4, 2026, at 4:00 PM CST, and responses must be submitted via email to Contract Specialist Sarah Fry at sarah.fry2@va.gov. All submissions failing to include the required documentation will be deemed non-compliant.

This procurement is set for Full and Open Competition with no set-aside designation applied. The solicitation calls for delivery of between 384 to 1,200 bottles per location across six VA CMOP facilities located in Chelmsford, Tucson, Lancaster, Murfreesboro, Hines, and Charleston. Delivery will occur via staggered monthly shipments over a three-month period, with the first delivery due 10 days after order receipt. The contract falls under Product Code 6505 (Drugs and Biologicals) and NAICS Code 325412 (Pharmaceutical Preparation Manufacturing). While no specific award value is disclosed in the presolicitation notice, the estimated issue date is February 25, 2026, and responses will be archived for 60 days following the March 4 deadline.